CXCR2 inhibition enables NASH-HCC immunotherapy - Leslie, Jack; Mackey, John B. G.; Jamieson, Thomas; Ramon-Gil, Erik; Drake, Thomas M.; Fercoq, Frédéric; Clark, William; Gilroy, Kathryn; Hedley, Ann; Nixon, Colin; Luli, Saimir; Laszczewska, Maja; et al. (Gut, 2022)
Gesehen am 15.07.2024